Last reviewed · How we verify
Myocardial Perfusion Imaging Adjunct
Approved treatments
- Adenocard · Astellas Pharma
- Regadenoson · Pfizer Inc.
Regadenoson is a low affinity A2A adenosine receptor agonist that produces coronary vasodilation and increases coronary blood flow. - Persantin · Boehringer Ingelheim
- Cytovene · Roche Palo
GANCICLOVIR works by inhibiting the DNA polymerase enzyme of cytomegalovirus, preventing viral replication. - Persantine · Boehringer Ingelheim
Persantine works by inhibiting platelet activation and aggregation by blocking the equilibrative nucleoside transporter 1. - Adenosin · University of Roma La Sapienza
- Lexiscan · Medical University of South Carolina
Clinical guidelines
- FDA label — adj
Regadenoson injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Myocardial Perfusion Imaging Adjunct patent landscape — cliff calendar, originator estates, attackable patents
- Myocardial Perfusion Imaging Adjunct treatment landscape brief
- Myocardial Perfusion Imaging Adjunct treatment updates RSS
Frequently asked questions about Myocardial Perfusion Imaging Adjunct
What drugs treat Myocardial Perfusion Imaging Adjunct?
Tracked treatments include Adenocard, Regadenoson, Persantin, Cytovene, Persantine, Adenosin, Lexiscan.
What is the treatment for Myocardial Perfusion Imaging Adjunct?
Standard treatment for Myocardial Perfusion Imaging Adjunct includes Adenocard, Regadenoson, Persantin, Cytovene, Persantine. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Myocardial Perfusion Imaging Adjunct?
FDA label publishes guidelines for Myocardial Perfusion Imaging Adjunct. 1 guideline references tracked.
Related
- Treatment landscape: Myocardial Perfusion Imaging Adjunct patent cliff · Myocardial Perfusion Imaging Adjunct CI report
- Treatment: Adenocard · Astellas Pharma
- Treatment: Regadenoson · Pfizer Inc.
- Treatment: Persantin · Boehringer Ingelheim
- Treatment: Cytovene · Roche Palo
- Treatment: Persantine · Boehringer Ingelheim
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing